Latest Headlines
-
Watchmaker Genomics Expands Molecular Diagnostics Tools Portfolio With Launch Of Stellar RT-qPCR And qPCR Kits
5/14/2026
Watchmaker Genomics, an innovator in high-performance tools for molecular diagnostic (MDx) assay developers, today announced the expansion of its MDx tools portfolio with the launch of Stellar RT-qPCR and qPCR Kits.
-
Synnovis And SOPHiA GENETICS Partner To Bring Blood-Based Cancer Testing To Patients Across The U.K
5/13/2026
SOPHiA GENETICS (NASDAQ: SOPH), a global leader in Ai-driven precision medicine, today announced a partnership with Synnovis, one of England's leading pathology providers, to bring liquid biopsy testing to lung and breast cancer patients across the U.K. as part of NHS England's 'revolutionary blood test-first' program.
-
ARUP Laboratories Launches National Infectious Disease Test Positivity Trends Dashboard
5/13/2026
ARUP Laboratories announced today the launch of its National Infectious Disease Test Positivity Trends Dashboard, the first tool developed by a U.S. reference laboratory to track laboratory test positivity trends for multiple pathogens.
-
PrognomiQ Announces Breakthrough Results For The Early Detection Of Lung Cancer In Ongoing Real-World Study For Its Novel Blood Test
5/12/2026
PrognomiQ, a healthcare company focused on harnessing the power of proteomics and multi-omics data to transform the detection and early treatment selection and monitoring of cancer, today announced encouraging early results from the first patients tested with ProVue Lung.
-
SanAir Expands Boston Environmental Testing Capabilities
5/12/2026
SanAir Technologies Laboratory, Inc. (SanAir), a division of Gillson Sciences and an accredited leader in environmental testing services, today announced that Asbestos Identification Lab (Asbestos ID) has joined their organization following a 15-year working partnership.
-
Labcorp And Epic Expand Collaboration To Advance Diagnostic Integration Across Hospitals And Health Systems
5/12/2026
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration with Epic, the nation's leading electronic health record (EHR) supporting hospitals and health systems.
-
Roche Receives CE Mark For New Blood Test To Detect Alzheimer's Pathology: Elecsys® Plasma Phosphorylated-Tau 217 (pTau217)
5/12/2026
Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that it has received CE Mark for Elecsys® pTau217, a blood test developed in collaboration with Eli Lilly and Company and designed to measure the phosphorylated Tau (pTau) 217 protein, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease.1,2,4,7,8
-
Evexia Diagnostics Partners With Immunosciences Lab To Expand Advanced Antibody Testing Access
5/12/2026
Evexia Diagnostics, a leading provider of comprehensive clinical laboratory services for integrative and functional medicine practitioners, is pleased to announce its partnership with Immunosciences Lab., Inc. (ISL), a pioneer and leader in clinical immunology.
-
20/20 BioLabs Exclusively Licenses PSA Velocity Algorithm From The University Of South Carolina
5/12/2026
20/20 BioLabs, Inc. (“20/20”) (Nasdaq: AIDX), an early market entrant in cutting-edge, AI powered laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, today announced that it has entered into an exclusive, worldwide licensing agreement with the University of South Carolina to commercialize a patented algorithm developed by a team headed by James Hébert, Sc.D., Director of the South Carolina Statewide Cancer Prevention and Control Program and Health Sciences Distinguished Professor in the Department of Epidemiology and Biostatistics.
-
Amcor Achieves CNAS Accreditation In China, Speeding Customer Access To Global Markets
5/11/2026
Amcor (NYSE: AMCR, ASX:AMC), a global leader in developing and producing responsible packaging solutions, today announced that its Asia Pacific Innovation Center (APIC) laboratory has received accreditation from the China National Accreditation Service for Conformity Assessment (CNAS), strengthening its role within Amcor's innovation ecosystem.